Pfizer's Talzenna To Compete With AZ's Lynparza In Breast Cancer After EU Okay

 
• By Kevin Grogan
Stags
Pfizer to lock horns with AZ in BRCA-mutated breast cancer market • Source: Shutterstock

More from Anticancer

More from Therapeutic Category